These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 27032493)

  • 1. Prevalence of inflammatory bowel disease among patients with primary sclerosing cholangitis in Iran.
    Hadizadeh M; Abedi SH; Malekpour H; Radinnia E; Jabbehdari S; Padashi M; Zali MR; Mohammad Alizadeh AH
    Arab J Gastroenterol; 2016 Mar; 17(1):17-9. PubMed ID: 27032493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients with large-duct primary sclerosing cholangitis and Crohn's disease have a better outcome than those with ulcerative colitis, or without IBD.
    Fevery J; Van Steenbergen W; Van Pelt J; Laleman W; Hoffman I; Geboes K; Vermeire S; Nevens F
    Aliment Pharmacol Ther; 2016 Mar; 43(5):612-20. PubMed ID: 26748470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is the association of primary sclerosing cholangitis with sex and inflammatory bowel disease in Turkish patients?
    Bayraktar Y; Arslan S; Saglam F; Uzunalimoglu B; Kayhan B
    Hepatogastroenterology; 1998; 45(24):2064-72. PubMed ID: 9951867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary sclerosing cholangitis associated with inflammatory bowel disease: an observational study in a Southern Europe population focusing on new therapeutic options.
    Franceschet I; Cazzagon N; Del Ross T; D'Incà R; Buja A; Floreani A
    Eur J Gastroenterol Hepatol; 2016 May; 28(5):508-13. PubMed ID: 26872110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary sclerosing cholangitis in patients with inflammatory bowel disease in Turkey.
    Parlak E; Kosar Y; Ulker A; Dagli U; Alkim C; Sahin B
    J Clin Gastroenterol; 2001 Oct; 33(4):299-301. PubMed ID: 11588543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis.
    Weismüller TJ; Trivedi PJ; Bergquist A; Imam M; Lenzen H; Ponsioen CY; Holm K; Gotthardt D; Färkkilä MA; Marschall HU; Thorburn D; Weersma RK; Fevery J; Mueller T; Chazouillères O; Schulze K; Lazaridis KN; Almer S; Pereira SP; Levy C; Mason A; Naess S; Bowlus CL; Floreani A; Halilbasic E; Yimam KK; Milkiewicz P; Beuers U; Huynh DK; Pares A; Manser CN; Dalekos GN; Eksteen B; Invernizzi P; Berg CP; Kirchner GI; Sarrazin C; Zimmer V; Fabris L; Braun F; Marzioni M; Juran BD; Said K; Rupp C; Jokelainen K; Benito de Valle M; Saffioti F; Cheung A; Trauner M; Schramm C; Chapman RW; Karlsen TH; Schrumpf E; Strassburg CP; Manns MP; Lindor KD; Hirschfield GM; Hansen BE; Boberg KM;
    Gastroenterology; 2017 Jun; 152(8):1975-1984.e8. PubMed ID: 28274849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [MRCP in primary sclerosing cholangitis].
    Weber C; Krupski G; Lorenzen J; Grotelüschen R; Seitz U; Rogiers X; Adam G
    Rofo; 2003 Feb; 175(2):203-10. PubMed ID: 12584620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of primary sclerosing cholangitis: a blinded comparative study using magnetic resonance cholangiography and endoscopic retrograde cholangiography.
    Moff SL; Kamel IR; Eustace J; Lawler LP; Kantsevoy S; Kalloo AN; Thuluvath PJ
    Gastrointest Endosc; 2006 Aug; 64(2):219-23. PubMed ID: 16860072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Appearance of hepatobiliary diseases in a population-based cohort with inflammatory bowel diseases (Inflammatory Bowel Disease Cohort of the Uppsala Region).
    Rönnblom A; Holmström T; Tanghöj H; Rorsman F; Sjöberg D
    J Gastroenterol Hepatol; 2015 Aug; 30(8):1288-92. PubMed ID: 25777994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of Sclerosing Cholangitis Detected by Magnetic Resonance Cholangiography in Patients With Long-term Inflammatory Bowel Disease.
    Lunder AK; Hov JR; Borthne A; Gleditsch J; Johannesen G; Tveit K; Viktil E; Henriksen M; Hovde Ø; Huppertz-Hauss G; Høie O; Høivik ML; Monstad I; Solberg IC; Jahnsen J; Karlsen TH; Moum B; Vatn M; Negård A
    Gastroenterology; 2016 Oct; 151(4):660-669.e4. PubMed ID: 27342213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    Barberio B; Massimi D; Cazzagon N; Zingone F; Ford AC; Savarino EV
    Gastroenterology; 2021 Dec; 161(6):1865-1877. PubMed ID: 34425093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary sclerosing cholangitis in the Swiss Inflammatory Bowel Disease Cohort Study: prevalence, risk factors, and long-term follow-up.
    Fraga M; Fournier N; Safroneeva E; Pittet V; Godat S; Straumann A; Nydegger A; Vavricka SR; Moradpour D; Schoepfer AM;
    Eur J Gastroenterol Hepatol; 2017 Jan; 29(1):91-97. PubMed ID: 27622999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with major radiological progression of primary sclerosing cholangitis in patients with inflammatory bowel disease.
    Azzam N; AlRuthia Y; Alharbi O; Aljebreen A; Almadi M; Loftus EV
    Hepatol Int; 2020 Dec; 14(6):1114-1124. PubMed ID: 33369708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigative MRI cholangiopancreatography for primary sclerosing cholangitis-type lesions in children with IBD.
    Alexopoulou E; Xenophontos PE; Economopoulos N; Spyridopoulos TN; Papakonstantinou O; Panayotou I; Dimakou K; Roma E; Kelekis NL
    J Pediatr Gastroenterol Nutr; 2012 Sep; 55(3):308-13. PubMed ID: 22569526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicentre Retrospective Cohort Study.
    Guerra I; Bujanda L; Castro J; Merino O; Tosca J; Camps B; Gutiérrez A; Gordillo Ábalos J; de Castro L; Iborra M; Carbajo AY; Taxonera C; Rodríguez-Lago I; Mesonero F; de Francisco R; Gómez-Gómez GJ; Chaparro M; Tardillo CA; Rivero M; Algaba A; Martín Arranz E; Cañete F; Vicente R; Sicilia B; Antolín B; Prieto V; Márquez L; Benítez JM; Camo P; Piqueras M; Gargallo CJ; Hinojosa E; Huguet JM; Pérez Calle JL; Van Domselaar M; Rodriguez C; Calvet X; Muñoz-Villafranca C; García-Sepulcre MF; Munoz-Garrido P; Fernández-Clotet A; Gómez Irwin L; Hernández S; Guardiola J; Sempere L; González Muñoza C; Hernández V; Beltrán B; Barrio J; Alba C; Moraleja I; López-Sanromán A; Riestra S; Martínez Montiel P; Garre A; Arranz L; García MJ; Martín Arranz MD; Corsino P; Arias L; Fernández-Salazar L; Fernández-Pordomingo A; Andreu M; Iglesias E; Ber Y; Mena R; Arroyo Villarino MT; Mora M; Ruiz L; López-Serrano P; Blazquez I; Villoria A; Fernández M; Bermejo F; Banales JM; Domènech E; Gisbert JP;
    J Crohns Colitis; 2019 Dec; 13(12):1492-1500. PubMed ID: 31063540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary sclerosing cholangitis associated with inflammatory bowel disease: an update.
    Rossi RE; Conte D; Massironi S
    Eur J Gastroenterol Hepatol; 2016 Feb; 28(2):123-31. PubMed ID: 26636407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrasting Pattern of Chronic Inflammatory Bowel Disease in Primary and Autoimmune Sclerosing Cholangitis.
    Bjarnason I; Hayee B; Pavlidis P; Kvasnovsky C; Scalori A; Sisson G; Charlesworth A; Shaikh H; Bjornsson E; Heneghan MA
    EBioMedicine; 2015 Oct; 2(10):1523-7. PubMed ID: 26629548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatobiliary dysfunction and primary sclerosing cholangitis in patients with Crohn's disease.
    Rasmussen HH; Fallingborg JF; Mortensen PB; Vyberg M; Tage-Jensen U; Rasmussen SN
    Scand J Gastroenterol; 1997 Jun; 32(6):604-10. PubMed ID: 9200295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Primary sclerosing cholangitis and inflammatory bowel disease].
    Schrumpf E; Fausa O; Aadland E; Elgjo K; Kolmannskog F
    Tidsskr Nor Laegeforen; 1990 Apr; 110(10):1212-6. PubMed ID: 1970674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical aspects and prognosis of patients with inflammatory bowel disease associated with autoimmune liver diseases.
    Rocha HC; Vilela EG
    Gastroenterol Hepatol; 2022 Feb; 45(2):83-90. PubMed ID: 34023469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.